DOI QR코드

DOI QR Code

Stereotactic Radiation Therapy for Nasal Carcinoma with Cribriform Plate Destruction in Three Dogs: A Serial CT Study

  • Soyon An (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Gunha Hwang (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Moonyeong Choi (S Animal Cancer Center) ;
  • Chan Huh (S Animal Cancer Center) ;
  • Young-Min Yoon (S Animal Cancer Center) ;
  • Hee Chun Lee (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Tae Sung Hwang (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
  • Received : 2023.01.30
  • Accepted : 2023.03.20
  • Published : 2023.04.30

Abstract

Three dogs were referred with epistaxis and facial deformity. Computed tomography (CT) scan identified masses in the bilateral nasal cavity with soft tissue attenuation and contrast enhancement. These masses had caused adjacent bones lysis, especially lysis of cribriform plate that extended to the intracranial region. Base on histopathology and CT imaging results, tumors were diagnosed as nasal carcinomas at stage 4. Three dogs were treated with stereotactic radiation therapy (SRT). These dogs received 30-35 Gy from 3-5 daily treatments (7-10 Gy per treatment). The sizes of tumors decreased the most on follow-up CT images at one month after treatment. Recurrence was confirmed between 3 and 5 months after completing SRT. The survival time of dogs treated with SRT were 110, 190, and 210 days, respectively. This study confirmed that SRT could treat canine nasal carcinomas with cribriform plate lysis without causing serious radiation toxicities. Follow-up CT examination is considered at 1 month and 3 to 6 months after SRT to accurately evaluate the prognosis and the timing of recurrence.

Keywords

References

  1. Adams WM, Kleiter MM, Thrall DE, Klauer JM, Forrest LJ, La Due TA, et al. Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors. Vet Radiol Ultrasound 2009; 50: 330-335.  https://doi.org/10.1111/j.1740-8261.2009.01545.x
  2. Adams WM, Withrow SJ, Walshaw R, Turrell JM, Evans SM, Walker MA, et al. Radiotherapy of malignant nasal tumors in 67 dogs. J Am Vet Med Assoc 1987; 191: 311-315. 
  3. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010; 37: 4078-4101. Erratum in: Med Phys 2012; 39: 563. Erratum in: Med Phys 2023. doi: 10.1002/mp.16159. [Epub ahead of print] 
  4. Fox-Alvarez S, Shiomitsu K, Lejeune AT, Szivek A, Kubicek L. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas. Vet Radiol Ultrasound 2020; 61: 370-378.  https://doi.org/10.1111/vru.12854
  5. Gieger TL, Nolan MW. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016). Vet Comp Oncol 2018; 16: E68-E75.  https://doi.org/10.1111/vco.12334
  6. Glasser SA, Charney S, Dervisis NG, Witten MR, Ettinger S, Berg J, et al. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors. J Am Anim Hosp Assoc 2014; 50: 96-104.  https://doi.org/10.5326/JAAHA-MS-6024
  7. Ladue T, Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound 2001; 42: 475-476.  https://doi.org/10.1111/j.1740-8261.2001.tb00973.x
  8. LaDue TA, Dodge R, Page RL, Price GS, Hauck ML, Thrall DE. Factors influencing survival after radiotherapy of nasal tumors in 130 dogs. Vet Radiol Ultrasound 1999; 40: 312-317.  https://doi.org/10.1111/j.1740-8261.1999.tb00367.x
  9. Lana SE, Turek MM. Tumors of the respiratory system. In: Vail DM, Thamm DH, Liptak JM, editors. Withrow and MacEwen's small animal clinical oncology. 6th ed. St. Louis: Elsevier Saunders. 2020: 492-523. 
  10. MacEwen EG, Withrow SJ, Patnaik AK. Nasal tumors in the dog: retrospective evaluation of diagnosis, prognosis, and treatment. J Am Vet Med Assoc 1977; 170: 45-48. 
  11. Madewell BR, Priester WA, Gillette EL, Snyder SP. Neoplasms of the nasal passages and paranasal sinuses in domesticated animals as reported by 13 veterinary colleges. Am J Vet Res 1976; 37: 851-856. 
  12. Mason SL, Maddox TW, Lillis SM, Blackwood L. Late presentation of canine nasal tumours in a UK referral hospital and treatment outcomes. J Small Anim Pract 2013; 54: 347-353.  https://doi.org/10.1111/jsap.12083
  13. Mayer MN, DeWalt JO, Sidhu N, Mauldin GN, Waldner CL. Outcomes and adverse effects associated with stereotactic body radiation therapy in dogs with nasal tumors: 28 cases (2011-2016). J Am Vet Med Assoc 2019; 254: 602-612.  https://doi.org/10.2460/javma.254.5.602
  14. Morgan MJ, Lurie DM, Villamil AJ. Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010-2016). BMC Res Notes 2018; 11: 70. 
  15. Mortier JR, Blackwood L. Treatment of nasal tumours in dogs: a review. J Small Anim Pract 2020; 61: 404-415.  https://doi.org/10.1111/jsap.13173
  16. Owen LN. TNM classification of tumours in domestic animals Geneva: World Health Organization. 1980: 1-53. 
  17. Patnaik AK. Canine sinonasal neoplasms: clinicopathological study of 285 cases. J Am Anim Hosp Assoc 1989; 25: 103-113. 
  18. Theon AP, Madewell BR, Harb MF, Dungworth DL. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. J Am Vet Med Assoc 1993; 202: 1469-1475.  https://doi.org/10.2460/javma.1993.202.09.1469
  19. Thrall DE, Heidner GL, Novotney CA, McEntee MC, Page RL. Failure pattern following cobalt irradiation in dogs with nasal carcinoma. Vet Radiol Ultrasound 1993; 34: 126-133.  https://doi.org/10.1111/j.1740-8261.1993.tb01521.x
  20. Weeden AM, Degner DA. Surgical approaches to the nasal cavity and sinuses. Vet Clin North Am Small Anim Pract 2016; 46: 719-733. https://doi.org/10.1016/j.cvsm.2016.02.004